일시 : 2025년 9월 20일(토)
장소 : 서울성모병원 지하 1층 대강당
Time | Title | Speaker & Chairperson |
---|---|---|
09:00-09:45 | 등록 | |
09:45-09:50 | 개회사 | 장윤수 (표적치료연구회 회장) |
09:50-09:55 | 축사 | 우홍균 (대한폐암학회 이사장) |
09:55-10:00 | 프로그램 소개 | 엄상원 (표적치료연구회 학술위원장) |
10:00-11:15 | Pathologic insights into the tumor immune microenvironment in lung cancer |
좌장 장선희 (인제의대) |
10:00-10:25 | Extracellular Hyaluronan Network Reprogrammed by ZEB1 Drives Lung Cancer Progression | 안영호 (이화의대) |
10:25-10:50 | Comprehensive analysis of the immune microenvironment in lung cancer | 고재문 (서울의대) |
10:50-11:15 | Decoding immunotherapy response through AI-driven modeling of tumor microenvironment landscapes | 김권일 (경희대) |
11:15-11:35 | Coffee Break | |
11:35-12:15 | Satellite Session |
좌장 양세훈 (원광의대) |
TEVIMBRA: A Novel PD-1 Inhibitor with Clinical Promise in NSCLC | 박동원 (한양의대) | |
12:15-13:15 | Lunch | |
13:15-14:05 | Session 1: Targeting tumor cells in lung cancer |
좌장 이재철 (울산의대) |
13:15-13:40 | Tumor heterogeneity and drug tolerant persister cell plasticity in lung cancer | 임준혁 (인하의대) |
13:40-14:05 | Recent advances in overcoming resistance to TKIs in NSCLC | 김수한 (부산의대) |
14:05-14:55 | Session 2: Targeting the tumor immune microenvironment(TIME) in lung cancer |
좌장 이신엽 (경북의대) |
14:05-14:30 | Role of tumor-associated macrophages and cancer-associated fibroblasts in lung cancer progression and immune evasion | 김보근 (성균관의대) |
14:30-14:55 | Targeting the TIME: from checkpoint inhibitors to novel Immunotherapies in lung cancer | 안준홍 (영남의대) |
14:55-15:15 | Coffee Break | |
15:15-16:30 | Session 3: Integration and future direction |
좌장 류정선 (인하의대) |
15:15-15:40 | Spatial transcriptomic analysis to explore tumor cell–TIME interactions | 서은섭 (지니너스) |
15:40-16:05 | Metabolic crosstalk between tumor cells and TIME | 박한수 (광주과학기술원, 지놈앤컴퍼니) |
16:05-16:30 | Co-targeting tumor cells and TIME in lung cancer | 박철규 (전남의대) |
16:30-16:50 | 숙제보고 | 김인애 (건국의대) |
16:50- | 폐회 |